Literature DB >> 15947251

Unraveling the links between diabetes, obesity, and cardiovascular disease.

Paul L Huang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15947251      PMCID： PMC3733534          DOI： 10.1161/01.RES.0000170705.56583.45

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  34 in total

1.  Leptin effect on endothelial nitric oxide is mediated through Akt-endothelial nitric oxide synthase phosphorylation pathway.

Authors:  Carmine Vecchione; Angelo Maffei; Salvatore Colella; Alessandra Aretini; Roberta Poulet; Giacomo Frati; Maria Teresa Gentile; Luigi Fratta; Valentina Trimarco; Bruno Trimarco; Giuseppe Lembo
Journal:  Diabetes       Date:  2002-01       Impact factor: 9.461

Review 2.  Does ADMA cause endothelial dysfunction?

Authors:  J P Cooke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-09       Impact factor: 8.311

3.  Membrane estrogen receptor engagement activates endothelial nitric oxide synthase via the PI3-kinase-Akt pathway in human endothelial cells.

Authors:  M P Haynes; D Sinha; K S Russell; M Collinge; D Fulton; M Morales-Ruiz; W C Sessa; J R Bender
Journal:  Circ Res       Date:  2000-10-13       Impact factor: 17.367

Review 4.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part II.

Authors:  Thomas F Lüscher; Mark A Creager; Joshua A Beckman; Francesco Cosentino
Journal:  Circulation       Date:  2003-09-30       Impact factor: 29.690

Review 5.  Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I.

Authors:  Mark A Creager; Thomas F Lüscher; Francesco Cosentino; Joshua A Beckman
Journal:  Circulation       Date:  2003-09-23       Impact factor: 29.690

6.  Leptin induces endothelial cell migration through Akt, which is inhibited by PPARgamma-ligands.

Authors:  Stephan Goetze; Anne Bungenstock; Cornelia Czupalla; Friedrich Eilers; Philipp Stawowy; Ulrich Kintscher; Chantel Spencer-Hänsch; Kristof Graf; Bernd Nürnberg; Ronald E Law; Eckart Fleck; Michael Gräfe
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

Review 7.  Post-translational control of endothelial nitric oxide synthase: why isn't calcium/calmodulin enough?

Authors:  D Fulton; J P Gratton; W C Sessa
Journal:  J Pharmacol Exp Ther       Date:  2001-12       Impact factor: 4.030

Review 8.  Regulation of endothelial nitric oxide synthase: location, location, location.

Authors:  Philip W Shaul
Journal:  Annu Rev Physiol       Date:  2002       Impact factor: 19.318

9.  Estrogen induces the Akt-dependent activation of endothelial nitric-oxide synthase in vascular endothelial cells.

Authors:  K Hisamoto; M Ohmichi; H Kurachi; J Hayakawa; Y Kanda; Y Nishio; K Adachi; K Tasaka; E Miyoshi; N Fujiwara; N Taniguchi; Y Murata
Journal:  J Biol Chem       Date:  2000-10-23       Impact factor: 5.157

Review 10.  Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress.

Authors:  H Cai; D G Harrison
Journal:  Circ Res       Date:  2000-11-10       Impact factor: 17.367
View more
  20 in total

Review 1.  A comprehensive definition for metabolic syndrome.

Authors:  Paul L Huang
Journal:  Dis Model Mech       Date:  2009 May-Jun       Impact factor: 5.758

2.  Determination of exact reconstruction regions in composite-circling cone-beam tomography.

Authors:  Lena Ye; Hengyong Yu; Ge Wang
Journal:  Med Phys       Date:  2009-08       Impact factor: 4.071

3.  Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy.

Authors:  Guangzhi Chen; Renfan Xu; Yinna Wang; Peihua Wang; Gang Zhao; Xizhen Xu; Artiom Gruzdev; Darryl C Zeldin; Dao Wen Wang
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-06-26       Impact factor: 4.310

Review 4.  Role of endothelial nitric oxide in cerebrovascular regulation.

Authors:  Dmitriy N Atochin; Paul L Huang
Journal:  Curr Pharm Biotechnol       Date:  2011-09       Impact factor: 2.837

5.  PPARγ activator, rosiglitazone: Is it beneficial or harmful to the cardiovascular system?

Authors:  Siripong Palee; Siriporn Chattipakorn; Arintaya Phrommintikul; Nipon Chattipakorn
Journal:  World J Cardiol       Date:  2011-05-26

6.  eNOS phosphorylation on serine 1176 affects insulin sensitivity and adiposity.

Authors:  Satoshi Kashiwagi; Dmitriy N Atochin; Qian Li; Michael Schleicher; Terrence Pong; William C Sessa; Paul L Huang
Journal:  Biochem Biophys Res Commun       Date:  2013-01-03       Impact factor: 3.575

Review 7.  Metabolic syndrome meets osteoarthritis.

Authors:  Qi Zhuo; Wei Yang; Jiying Chen; Yan Wang
Journal:  Nat Rev Rheumatol       Date:  2012-08-21       Impact factor: 20.543

Review 8.  eNOS, metabolic syndrome and cardiovascular disease.

Authors:  Paul L Huang
Journal:  Trends Endocrinol Metab       Date:  2009-07-31       Impact factor: 12.015

Review 9.  Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice.

Authors:  Victor W T Liu; Paul L Huang
Journal:  Cardiovasc Res       Date:  2008-01       Impact factor: 10.787

10.  The phosphorylation state of eNOS modulates vascular reactivity and outcome of cerebral ischemia in vivo.

Authors:  Dmitriy N Atochin; Annie Wang; Victor W T Liu; Jeffrey D Critchlow; Ana Paula V Dantas; Robin Looft-Wilson; Takahisa Murata; Salvatore Salomone; Hwa Kyoung Shin; Cenk Ayata; Michael A Moskowitz; Thomas Michel; William C Sessa; Paul L Huang
Journal:  J Clin Invest       Date:  2007-07       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.